Weichang Zhou
Directeur/Bestuurslid bij WUXI BIOLOGICS (CAYMAN) INC.
Vermogen: 434 164 $ op 30-04-2024
Actieve functies van Weichang Zhou
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
WUXI BIOLOGICS (CAYMAN) INC. | Directeur/Bestuurslid | 01-05-2016 | - |
Hoofd Techniek/Wetenschap/O&O | 01-11-2016 | 31-03-2024 | |
WUXI XDC CAYMAN INC. | Directeur/Bestuurslid | 01-12-2020 | - |
Loopbaan van Weichang Zhou
Eerdere bekende functies van Weichang Zhou
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
Genzyme Corp.
Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Directeur/Bestuurslid | 01-03-2008 | 01-12-2012 |
PDL BIOPHARMA, INC. | Directeur/Bestuurslid | 01-10-2002 | 01-02-2008 |
MERCK & CO., INC. | Corporate Officer/Principal | 01-05-1994 | 01-10-2002 |
Opleiding van Weichang Zhou
Jiangxi University of Science & Technology | Undergraduate Degree |
University of Hannover | Doctorate Degree |
Statistieken
Internationaal
Verenigde Staten | 4 |
China | 3 |
Duitsland | 2 |
Operationeel
Director/Board Member | 4 |
Chief Tech/Sci/R&D Officer | 1 |
Corporate Officer/Principal | 1 |
Sectoraal
Health Technology | 5 |
Consumer Services | 3 |
Commercial Services | 2 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
Beursgenoteerde bedrijven | 3 |
---|---|
WUXI BIOLOGICS (CAYMAN) INC. | Health Technology |
MERCK & CO., INC. | Health Technology |
WUXI XDC CAYMAN INC. | Commercial Services |
Bedrijven in privébezit | 2 |
---|---|
Genzyme Corp.
Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Health Technology |
PDL BioPharma, Inc.
PDL BioPharma, Inc. BiotechnologyHealth Technology PDL BioPharma, Inc. engages in the business of developing innovative therapeutics and healthcare technologies. It operates under the Medical Devices and Income Generating Assets segments. The Medical Devices segment focuses on the sale and lease of the LENSAR laser system which includes equipment, patient interface devices, procedure licenses, training, installation, warranty, and maintenance agreements. The Income Generating Assets segment offers notes and other long-term receivables; royalty rights, hybrid notes, and royalty receivables; equity investments; and royalties from issued patents covering the humanization of antibodies. The company was founded by Cary L. Queen and Laurence Jay Korn in 1986 and is headquartered in Reno, NV. | Health Technology |
- Beurs
- Insiders
- Weichang Zhou
- Ervaring